Get the Stockscreener App
5.135
0.48%
-0.045
Organogenesis Holdings Inc stock is traded at $5.135, with a volume of 238.13K.
It is down -0.48% in the last 24 hours and up +21.29% over the past month.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
See More
Previous Close:
$5.18
Open:
$5.18
24h Volume:
238.13K
Relative Volume:
0.17
Market Cap:
$651.69M
Revenue:
$433.14M
Net Income/Loss:
$4.95M
P/E Ratio:
143.84
EPS:
0.0357
Net Cash Flow:
$6.55M
1W Performance:
-4.36%
1M Performance:
+21.29%
6M Performance:
+88.14%
1Y Performance:
+33.20%
1-Day Range:
$5.095
$5.21
1-Week Range:
$5.095
$5.57
52-Week Range:
$2.6101
$7.0771
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Name
Organogenesis Holdings Inc
Sector
Phone
781-575-0775
Address
85 DAN ROAD, CANTON, MA
Compare ORGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
5.135 | 657.40M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
128.91 | 56.49B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.49 | 45.56B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.865 | 43.55B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
26.70 | 30.85B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
482.17 | 20.93B | 3.08B | 1.24B | 1.07B | 25.61 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Lake Street | Buy |
| Feb-07-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-15-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-24-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-10-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-10-20 | Initiated | SVB Leerink | Outperform |
| Aug-26-19 | Resumed | Credit Suisse | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
| Apr-17-19 | Initiated | Oppenheimer | Outperform |
| Apr-11-19 | Initiated | SunTrust | Buy |
View All
Organogenesis Holdings Inc Stock (ORGO) Latest News
Have Organogenesis Holdings Insiders Been Selling Stock? - simplywall.st
Organogenesis Holdings Insider Sold Shares Worth $1,592,120, According to a Recent SEC Filing - MarketScreener
Organogenesis director Nussdorf sells $1.59 million in shares By Investing.com - Investing.com Australia
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Shares Bounce 27% But Its Business Still Trails The Industry - simplywall.st
Organogenesis director Nussdorf sells $1.59 million in shares - Investing.com
Dir Nussdorf Sells 300,000 ($1.6M) Of Organogenesis Holdings Inc [ORGO] - TradingView
Dir Nussdorf Files To Sell 200,000 Of Organogenesis Holdings Inc [ORGO] - TradingView
Dir Nussdorf Files To Sell 100,000 Of Organogenesis Holdings Inc [ORGO] - TradingView
Organogenesis (NASDAQ:ORGO) Price Target Raised to $9.00 - Defense World
Organogenesis Holdings (NASDAQ:ORGO) pulls back 8.4% this week, but still delivers shareholders solid 26% CAGR over 3 years - Yahoo Finance
Organogenesis Holdings (NASDAQ:ORGO) pulls back 8.4% this week, but still delivers shareholders splendid 26% CAGR over 3 years - simplywall.st
Organogenesis (NASDAQ:ORGO) Trading Up 6.2% After Analyst Upgrade - Defense World
Organogenesis Holdings Inc.Class A (NQ: ORGO - Markets Financial Content
Is Organogenesis Holdings Inc. (2PQ) stock supported by strong fundamentalsPortfolio Profit Report & Weekly Stock Performance Updates - newser.com
Organogenesis stock price target raised to $9 by BTIG on reimbursement changes - Investing.com South Africa
Global Wound Healing Devices Market Poised for Robust Growth at a CAGR of ~5% by 2032, Driven by Rising Chronic Wound Burden | DelveInsight - GlobeNewswire Inc.
What makes Organogenesis Holdings Inc. (2PQ) stock appealing to growth investorsMarket Volume Summary & Fast Exit and Entry Strategy Plans - newser.com
Can Organogenesis Holdings Inc. stock surprise with earnings upsideJuly 2025 Closing Moves & High Accuracy Trade Alerts - newser.com
Will Organogenesis Holdings Inc. stock attract more institutional investorsQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
How dovish Fed policy supports Organogenesis Holdings Inc. (2PQ) stock2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock supported by free cash flowWeekly Stock Analysis & Daily Entry Point Trade Alerts - newser.com
Will Organogenesis Holdings Inc. stock maintain dividend yieldPortfolio Risk Summary & Low Risk Entry Point Tips - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock at risk of policy regulationWeekly Stock Summary & AI Powered Market Entry Ideas - newser.com
Is Organogenesis Holdings Inc. stock positioned for digital transformation2025 Price Momentum & Fast Gain Stock Trading Tips - newser.com
Can Organogenesis Holdings Inc. rally from current levelsGold Moves & Safe Entry Zone Tips - newser.com
Using Python tools to backtest Organogenesis Holdings Inc. strategies2025 Performance Recap & Real-Time Volume Analysis - newser.com
Detecting price anomalies in Organogenesis Holdings Inc. with AIDollar Strength & Safe Swing Trade Setup Alerts - newser.com
Is Organogenesis Holdings Inc. showing signs of accumulationJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
Exit strategy if you’re trapped in Organogenesis Holdings Inc.Earnings Growth Summary & Accurate Entry/Exit Alerts - newser.com
How Organogenesis Holdings Inc. (2PQ) stock benefits from digital adoptionEarnings Trend Report & Daily Technical Forecast Reports - newser.com
The growth track for Organogenesis Holdings Inc (ORGO) has changed recently - Setenews
Organogenesis Holdings Inc Stock (ORGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Organogenesis Holdings Inc Stock (ORGO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| NUSSDORF GLENN H | Director |
Nov 24 '25 |
Sale |
5.34 |
100,000 |
534,000 |
2,965,591 |
| NUSSDORF GLENN H | Director |
Nov 25 '25 |
Sale |
5.30 |
12,043 |
63,828 |
2,953,548 |
3.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):